Neurology Fellowship

About the Fellowship Opportunities

The University of Pittsburgh, in partnership with the Pittsburgh Institute for Multiple Sclerosis Care and Research and UPMC Medical Education, is pleased to offer fellowships for the 2026-2027 academic year. Applications are accepted through January 31, 2026.

We offer three distinct subspecialty tracks designed to provide balanced training experiences that integrate structured didactics, scholarly activities, and clinical excellence. Our program places a special emphasis on career development and subspecialty board preparation, ensuring fellows can thrive professionally while enjoying a high quality of life in Pittsburgh.

Clinical Neuroimmunology and Multiple Sclerosis

This ACGME-accredited neuromuscular fellowship offers a focused path in clinical neuroimmunology and multiple sclerosis care.

NeuroOncology

For the 2026-2027 year, we offer a NeuroOncology fellowship with an optional second research year for interested applicants. This track is designed for individuals currently in their fourth year of an ACGME-accredited Neurology residency program.

Women's Neurology

Beginning July 2026, our Women's Neurology fellowship provides specialized training at the interface between neurological disorders and women's health across the lifespan. This program is flexible, allowing fellows to train directly after neurology residency or before or after other neurological subspecialty fellowships.

Fellows train alongside top experts in the field, including Women's Neurology Division Chief Dr. Eliza Miller, Chair of Neurology Dr. Page Pennell, and Fellowship Director Dr. Angela O'Neal. Training takes place within an integrated multidisciplinary practice setting at Magee-Womens Hospital, where over 10,000 deliveries occur annually. Fellows will collaborate with multiple subspecialists dedicated to women's neurological health. Qualified candidates pursuing a clinical research track will be supported with up to 50% protected time for research, with elective time tailored to individual clinical and research interests.